Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 35

1.

Comparison of antipseudomonal β-lactams for febrile neutropenia empiric therapy: systematic review and network meta-analysis.

Horita N, Shibata Y, Watanabe H, Namkoong H, Kaneko T.

Clin Microbiol Infect. 2017 Oct;23(10):723-729. doi: 10.1016/j.cmi.2017.03.024. Epub 2017 Apr 1. Review.

PMID:
28377312
2.

Antibiotics for ventilator-associated pneumonia.

Arthur LE, Kizor RS, Selim AG, van Driel ML, Seoane L.

Cochrane Database Syst Rev. 2016 Oct 20;10:CD004267. Review.

PMID:
27763732
3.

Ceftazidime/Avibactam: A New Antibiotic for Gram-Negative Infections.

Chahine EB, Sourial M, Ortiz R.

Consult Pharm. 2015 Dec;30(12):695-705. doi: 10.4140/TCP.n.2015.695. Review.

PMID:
26671269
4.

Oral and intramuscular treatment options for early postpartum endometritis in low-resource settings: a systematic review.

Meaney-Delman D, Bartlett LA, Gravett MG, Jamieson DJ.

Obstet Gynecol. 2015 Apr;125(4):789-800. doi: 10.1097/AOG.0000000000000732. Review. Erratum in: Obstet Gynecol. 2015 Aug;126(2):452-3.

PMID:
25751198
5.

Therapeutic guidelines for prescribing antibiotics in neonates should be evidence-based: a French national survey.

Leroux S, Zhao W, Bétrémieux P, Pladys P, Saliba E, Jacqz-Aigrain E; French Society of Neonatology.

Arch Dis Child. 2015 Apr;100(4):394-8. doi: 10.1136/archdischild-2014-306873. Epub 2015 Jan 27.

6.

The risk of seizures among the carbapenems: a meta-analysis.

Cannon JP, Lee TA, Clark NM, Setlak P, Grim SA.

J Antimicrob Chemother. 2014 Aug;69(8):2043-55. doi: 10.1093/jac/dku111. Epub 2014 Apr 16.

PMID:
24744302
7.

[Evaluation of the efficacy and safety of tigecycline for treatment of respiratory tract infections: systematic review of literature].

Moya Cordero P, Ruiz-Aragón J, Molina Linde JM, Márquez-Peláez S, Motiva Sánchez V.

Rev Chilena Infectol. 2013 Dec;30(6):591-7. doi: 10.4067/S0716-10182013000600002. Review. Spanish.

8.

Antimicrobial stewardship program implementation in a medical intensive care unit at a tertiary care hospital in Saudi Arabia.

Amer MR, Akhras NS, Mahmood WA, Al-Jazairi AS.

Ann Saudi Med. 2013 Nov-Dec;33(6):547-54. doi: 10.5144/0256-4947.2013.547.

9.

Systematic review and meta-analysis of antimicrobial treatment effect estimation in complicated urinary tract infection.

Singh KP, Li G, Mitrani-Gold FS, Kurtinecz M, Wetherington J, Tomayko JF, Mundy LM.

Antimicrob Agents Chemother. 2013 Nov;57(11):5284-90. doi: 10.1128/AAC.01257-13. Epub 2013 Aug 12. Review.

10.

Sulbactam-based therapy for Acinetobacter baumannii infection: a systematic review and meta-analysis.

Chu H, Zhao L, Wang M, Liu Y, Gui T, Zhang J.

Braz J Infect Dis. 2013 Jul-Aug;17(4):389-94. doi: 10.1016/j.bjid.2012.10.029. Epub 2013 Apr 19. Review.

11.

Evaluation of antibiotic prescribing patterns in patients receiving sustained low-efficiency dialysis: opportunities for pharmacists.

Harris LE, Reaves AB, Krauss AG, Griner J, Hudson JQ.

Int J Pharm Pract. 2013 Feb;21(1):55-61. doi: 10.1111/j.2042-7174.2012.00226.x. Epub 2012 Jul 9.

PMID:
23301534
12.

Doripenem: excess mortality.

[No authors listed]

Prescrire Int. 2012 Sep;21(130):214. No abstract available.

PMID:
23016255
13.

New insights into meticillin-resistant Staphylococcus aureus (MRSA) pathogenesis, treatment and resistance.

Gould IM, David MZ, Esposito S, Garau J, Lina G, Mazzei T, Peters G.

Int J Antimicrob Agents. 2012 Feb;39(2):96-104. doi: 10.1016/j.ijantimicag.2011.09.028. Epub 2011 Dec 21. Review.

PMID:
22196394
14.

Vancomycin-resistant enterococcal urinary tract infections.

Heintz BH, Halilovic J, Christensen CL.

Pharmacotherapy. 2010 Nov;30(11):1136-49. doi: 10.1592/phco.30.11.1136. Review.

PMID:
20973687
15.

Empiric, broad-spectrum antibiotic therapy with an aggressive de-escalation strategy does not induce gram-negative pathogen resistance in ventilator-associated pneumonia.

Hibbard ML, Kopelman TR, O'Neill PJ, Maly TJ, Matthews MR, Cox JC, Vail SJ, Quan AN, Drachman DA.

Surg Infect (Larchmt). 2010 Oct;11(5):427-32. doi: 10.1089/sur.2009.046.

PMID:
20818984
16.

Carbapenems versus other beta-lactams in the treatment of hospitalised patients with infection: a mixed treatment comparison.

Edwards SJ, Clarke MJ, Wordsworth S, Welton NJ.

Curr Med Res Opin. 2009 Jan;25(1):251-61. doi: 10.1185/03007990802633160 .

PMID:
19210156
17.

Management and prevention of diabetic foot ulcers and infections: a health economic review.

Chow I, Lemos EV, Einarson TR.

Pharmacoeconomics. 2008;26(12):1019-35. doi: 10.2165/0019053-200826120-00005. Review.

PMID:
19014203
18.

Tigecycline: a novel broad-spectrum antimicrobial.

Slover CM, Rodvold KA, Danziger LH.

Ann Pharmacother. 2007 Jun;41(6):965-72. Epub 2007 May 22. Review.

PMID:
17519296
19.

Cilastatin protection against cyclosporin A-induced nephrotoxicity: clinical evidence.

Tejedor A, Torres AM, Castilla M, Lazaro JA, de Lucas C, Caramelo C.

Curr Med Res Opin. 2007 Mar;23(3):505-13. Review.

PMID:
17355732
20.

Pneumonia due to Pseudomonas aeruginosa: the levofloxacin clinical trials experience.

Tennenberg AM, Davis NB, Wu SC, Kahn J.

Curr Med Res Opin. 2006 May;22(5):843-50.

PMID:
16709306

Supplemental Content

Loading ...
Support Center